Radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma (vol 352, pg 19, 2005)

被引：0
|
作者：
Stupp, R
Mason, WP
van den Beuf, MJ
机构：
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：949 / 949
页数：1
相关论文
共 50 条
  • [41] Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme: A Systematic Review
    Yang, Li-Juan
    Zhou, Chang-Fu
    Lin, Zhi-Xiong
    CANCER INVESTIGATION, 2014, 32 (02) : 31 - 36
  • [42] Treatment of newly diagnosed high-grade glioma with concomitant and adjuvant temozolomide and radiotherapy - UK experience
    Beresford, M.
    Thompson, J.
    Power, D.
    Glaser, M.
    EJC SUPPLEMENTS, 2005, 3 (02): : 141 - 141
  • [43] Early platelet variation during concomitant chemo-radiotherapy predicts adjuvant temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma patients
    Fontanilles, Maxime
    Marguet, Florent
    Alexandru, Cristina
    Langlois, Olivier
    Veresezan, Ovidiu
    Gilard, Vianney
    David, Marion
    Laquerriere, Annie
    Hanzen, Chantal
    Tennevet, Isabelle
    Di Fiore, Frederic
    Clatot, Florian
    SUPPORTIVE CARE IN CANCER, 2019, 27 (02) : 477 - 484
  • [44] Early platelet variation during concomitant chemo-radiotherapy predicts adjuvant temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma patients
    Maxime Fontanilles
    Florent Marguet
    Cristina Alexandru
    Olivier Langlois
    Ovidiu Veresezan
    Vianney Gilard
    Marion David
    Annie Laquerriere
    Chantal Hanzen
    Isabelle Tennevet
    Frédéric Di Fiore
    Florian Clatot
    Supportive Care in Cancer, 2019, 27 : 477 - 484
  • [45] Early platelet variation during concomitant chemo-radiotherapy predicts adjuvant temozolomide-induced thrombocytopenia in newly-diagnosed glioblastoma
    Fontanilles, M.
    Clatot, F.
    Alexandru, C.
    Langlois, O.
    Veresezan, O.
    Marguet, F.
    David, M.
    Laquerriere, A.
    Hanzen, C.
    Bouilly, I. Tennevet
    Di Fiore, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [46] Performance status during and after radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma multiforme
    Lee, Jeong-Heon
    Jung, Tae-Young
    Jung, Shin
    Kim, In-Young
    Jang, Woo-Youl
    Moon, Kyung-Sub
    Jeong, Eun-Hui
    JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (04) : 503 - 508
  • [47] The efficacy of hypofractionated radiotherapy (HFRT) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: A meta-analysis
    Guo, Longbin
    Li, Xuanzi
    Chen, Yulei
    Liu, Rongping
    Ren, Chen
    Du, Shasha
    CANCER RADIOTHERAPIE, 2021, 25 (02): : 182 - 190
  • [48] Radiotherapy plus adjuvant temozolomide for the treatment of glioblastoma - a paradigm shift
    Fine, HA
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (07): : 334 - 335
  • [49] Radiotherapy plus adjuvant temozolomide for the treatment of glioblastoma—a paradigm shift
    Howard A Fine
    Nature Clinical Practice Oncology, 2005, 2 : 334 - 335
  • [50] Radiochemotherapy with daily concomitant and adjuvant one week on/one week off temozolomide plus indomethacin in newly diagnosed glioblastoma: A phase II trial
    Weiler, M.
    Hartmann, C.
    Wiewrodt, D.
    Herrlinger, U.
    Schuth, J.
    Bamberg, M.
    von Deimling, A.
    Weller, M.
    Wick, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345